Shanghai Pharmaceuticals Holding Co (SHSE:601607) 3-Year Book Growth Rate : 5.10% (As of Sep. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co 3-Year Book Growth Rate?

Shanghai Pharmaceuticals Holding Co's Book Value per Share for the quarter that ended in Sep. 2024 was ¥19.13.

During the past 12 months, Shanghai Pharmaceuticals Holding Co's average Book Value per Share Growth Rate was 3.40% per year. During the past 3 years, the average Book Value per Share Growth Rate was 5.10% per year. During the past 5 years, the average Book Value per Share Growth Rate was 6.50% per year. During the past 10 years, the average Book Value per Share Growth Rate was 7.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Shanghai Pharmaceuticals Holding Co was 74.00% per year. The lowest was -14.30% per year. And the median was 7.40% per year.

Competitive Comparison of Shanghai Pharmaceuticals Holding Co's 3-Year Book Growth Rate

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Pharmaceuticals Holding Co's 3-Year Book Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's 3-Year Book Growth Rate falls into.

Shanghai Pharmaceuticals Holding Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Shanghai Pharmaceuticals Holding Co (SHSE:601607) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Shanghai Pharmaceuticals Holding Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Pharmaceuticals Holding Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (SHSE:601607) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

SHPMY:USA SHPMF:USA 02607:Hong Kong S1R:Germany

Address

No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020

Website

https://www.sphchina.com

Shanghai Pharmaceuticals is the second-largest medical distributor in China by revenue. It is vertically integrated and provides healthcare services in research and development, manufacturing, distribution, and retail. As of 2023, medical distribution is the largest segment, accounting for 89.8% of total revenue. It also has coverage of 31 provinces and cities nationwide.

Executives

Ren Jian	senior management
Liu Yan Jun	senior management
Hu Feng Xiang	Director
Zuo Min	Director
Guo Jun Yu	senior management
Han Min	senior management
Lou Ding Bo	Director
Chen Xin	Supervisors
Shu Chang	senior management
Li Yong Zhong	senior management
Jiang Yuan Ying	senior management
Xu Guo Xiong	Director
Shen Bo	senior management
Ge Jian Qiu	senior management

Shanghai Pharmaceuticals Holding Co Headlines

No Headlines